ストックスクリーナーアプリを入手
35.64
1.57%
-0.57
アフターアワーズ：
35.64
前日終値:
$36.21
開ける：
$36.51
24時間の取引高:
1.08M
Relative Volume:
0.58
時価総額：
$4.60B
収益：
-
当期純損益:
$-507.65M
株価収益率:
-7.7478
EPS:
-4.6
ネットキャッシュフロー:
$-616.24M
1週間 パフォーマンス:
-2.03%
1か月 パフォーマンス:
+8.43%
6か月 パフォーマンス:
-59.58%
1年 パフォーマンス:
-56.34%
1日の値動き範囲:
$35.38
$37.44
1週間の範囲:
$34.89
$37.95
52週間の値動き範囲:
$27.66
$121.06
Vaxcyte Inc Stock (PCVX) Company Profile
名前
Vaxcyte Inc
セクター
電話
650-837-0111
住所
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA
PCVX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PCVX
Vaxcyte Inc
|
35.64 | 4.69B | 0 | -507.65M | -616.24M | -4.60 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.49 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.53 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.52 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
566.14 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.93 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
Vaxcyte Inc Stock (PCVX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-22 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-12-20 | 開始されました | Goldman | Buy |
| 2023-12-07 | 開始されました | Mizuho | Buy |
| 2023-04-18 | 開始されました | TD Cowen | Outperform |
| 2023-01-03 | 繰り返されました | Needham | Buy |
| 2022-12-15 | 開始されました | Guggenheim | Buy |
| 2022-11-17 | 開始されました | BTIG Research | Buy |
| 2021-12-29 | 再開されました | Jefferies | Buy |
| 2021-06-24 | 再開されました | Jefferies | Buy |
| 2020-07-07 | 開始されました | BofA Securities | Buy |
| 2020-07-07 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-07-07 | 開始されました | Needham | Buy |
すべてを表示
Vaxcyte Inc (PCVX) 最新ニュース
What analysts say about Vaxcyte Inc. stockRapidly growing investment returns - Autocar Professional
What drives Vaxcyte Inc. stock priceSpectacular growth rates - jammulinksnews.com
Is Vaxcyte Inc. a good long term investmentOverwhelming financial success - Autocar Professional
Vaxcyte Inc. Stock Analysis and ForecastExponential wealth increase - jammulinksnews.com
Mizuho Maintains an Overweight Rating on Vaxcyte (PCVX) - MSN
Nisa Investment Advisors LLC Buys 293 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - Defense World
How the (PCVX) price action is used to our Advantage - news.stocktradersdaily.com
Vaxcyte’s High-Stakes Bet On Next-Gen Pneumonia Vaccines - Finimize
What makes Vaxcyte Inc. stock price move sharplyBreakout Momentum Stocks - beatles.ru
Why Vaxcyte Inc. stock attracts strong analyst attentionBig Profit Small Risk Alerts - Newser
How Vaxcyte Inc. stock performs during market volatilityRisk Adjusted Stock Signals - Newser
Teacher Retirement System of Texas Sells 2,779 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - Defense World
Here’s Why Vaxcyte (PCVX) Sold Off in Q1 - Insider Monkey
(PCVX) Trading Advice - news.stocktradersdaily.com
Cantor Fitzgerald Maintains Overweight on Vaxcyte Amid Vaccine Development and ACIP Meeting - MSN
Vaxcyte (PCVX): Riding Passive Fund Winds to FDA Catalysts – A Tactical Play with Strategic Upside - AInvest
Vaxcyte, Inc.(NasdaqGS: PCVX) added to Russell 2500 Value Index - MarketScreener
Russell Reconstitution and Options Surge: Vaxcyte's Institutional Crossroads - AInvest
Vaxcyte Holds Annual Stockholders Meeting on Governance - TipRanks
How To Trade (PCVX) - news.stocktradersdaily.com
Cantor Fitzgerald Estimates Vaxcyte FY2026 Earnings - Defense World
Transcript : Vaxcyte, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 01 - MarketScreener
Vaxcyte: Sentiment Is Pushing The Shares Down (NASDAQ:PCVX) - Seeking Alpha
Cantor Fitzgerald maintains Overweight on Vaxcyte shares By Investing.com - Investing.com Canada
Vaxcyte, Inc. (NASDAQ:PCVX) Given Consensus Rating of “Buy” by Analysts - Defense World
(PCVX) Long Term Investment Analysis - news.stocktradersdaily.com
Head to Head Contrast: Vaxcyte (NASDAQ:PCVX) and Beam Therapeutics (NASDAQ:BEAM) - Defense World
Vaxcyte (VCYT) Jumps Over 4.5%: Is This Biotech Eyeing a Return Towards Its $121 High? - Daily Chhattisgarh News
Vaxcyte, Inc. (PCVX) Stock Analysis: Unpacking the 286% Potential Upside for Investors - DirectorsTalk Interviews
James T. Wassil ’99G ’05G of Vaxcyte Inc., Tells Graduates ‘The Journey Ahead is Yours to Shape’ - Lehigh University
Transcript : Vaxcyte, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 08 - marketscreener.com
Research Analysts Set Expectations for Vaxcyte Q3 Earnings - Defense World
Vaxcyte Inc (PCVX) 財務データ
収益
当期純利益
現金流量
EPS
0.87%
0.17%
大文字化:
|
ボリューム (24 時間):